NEKTAR THERAPEUTICS — Director's Dealing 2017

Sep 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2017-09-19

Reporting Person: WINGER DENNIS L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-19	Common Stock	A	9000	$0.00	Acquired	43250	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-19	Stock Option	$21.75	A	22500	Acquired	2025-09-18	common stock (22500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5000	Indirect

Footnotes

F1: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.

F2: This restricted stock unit award vests in full, one year following September 19, 2017.

F3: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2017.